This course will expand on both classical and cutting edge pharmacological strategies proposed to mitigate the consequences of altered signal transduction in cancer. Students will have the opportunity to develop knowledge on these molecular events and how they can be targeted to improve clinical outcomes. Students will integrate lecture material with assigned readings and assignments.